Snakebites are well-known medical emergencies in many parts of the world especially in rural areas. Agricultural workers and children are most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortality and morbidity due to snake bites. These guidelines are a revised and updated version of those published in 2011. The geographical coverage extends from India in the west to DPR Korea and Indonesia in the east Nepal and Bhutan in the north and to Sri Lanka and Indonesia in the south and south-east. Snakes inhabiting the Indonesian islands east of Wallace?s line (West Papua and Maluku Islands) are part of the Australasian elapid fauna differing from those west of this line. This publication aims to pass on a digest of available knowledge about all clinical aspects of snake-bite to medically trained personnel including medical doctors nurses dispensers and community health workers. They aim to provide suffcient practical information to allow medically trained personnel to assess and treat patients with snake-bites at different levels of the health service.
In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region these two parallel guidelines one for small hospitals and another one for large hospitals were developed for use by medical personnel who treat severe malaria patients referred from lower-level health facilities. These guidelines were developed by the WHO Regional Office for South-East Asia and the WHO Collaborating Centre for the Clinical Management of Malaria Faculty of Tropical Medicine Mahidol University Thailand. They are based on a review of current evidence existing WHO guidelines and experience in the management of malaria in the Region.
In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region these two parallel guidelines one for small hospitals and another one for large hospitals were developed for use by medical personnel who treat severe malaria patients referred from lower-level health facilities. These guidelines were developed by the WHO Regional Office for South-East Asia and the WHO Collaborating Centre for the Clinical Management of Malaria Faculty of Tropical Medicine Mahidol University Thailand. They are based on a review of current evidence existing WHO guidelines and experience in the management of malaria in the Region.
WHO's concern is that, despite national and global efforts to control malaria, the disease burden remains high, especially in tropical Africa. The situation is further compounded in emergency situations. It is therefore necessary to review the current vector control strategies and their effectiveness in various operational and eco-epidemiological settings and to identify the challenges for implementation in different health systems. These would serve as a basis for the development of a strategic framework for strengthening malaria vector control implementation. The Roll Back Malaria (RBM) Initiative was launched by the WHO Director-General in 1998 as a Cabinet Project to coordinate global actions against malaria. The RBM goal is to reduce the global malaria burden by half by 2010 as compared to 2000"--Publisher's statement
There is serious concern about the impact of the changing climate. The WHO Regional Office for the Western Pacific has taken the initiative in addressing health issues related to climate change but further action is needed to support efforts to confront climate change in Member States and in various sectors. Health must be mainstreamed into efforts to address climate change and action must be coordinated and integrated across national boundaries and in all sectors. This report synthesizes information and approaches on climate change and health pertinent to Member States in the Western Pacific Region. It also examines efforts and initiatives by various experts and stakeholders with an in-depth look at experiences in seven Member States that reflect the diversity of the Region. Finally it offers recommendations for policy-makers.
This publication is the first bi-regional report on tuberculosis control in the South-East Asia and the Western Pacific Regions. It presents data on TB epidemiology and gauges the enormous progress being made by national TB control programmes in both the regions. It presents the overall success with strategies adopted to control TB and highlights the similarities and differences between individual countries.
Report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children).
Report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children).
The 19th Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicine took place in Geneva, Switzerland, from 8 to 12 April 2013"--P. vii.
This report deals primarily with the analysis of the drinking-water and sanitation situation in the member countries of the Thematic Working Group on Water Sanitation and Hygiene (TWG WSH) based on statistics published by the World Health Organization (WHO) and United Nations Children s Fund (UNICEF) Joint Monitoring Programme for Water Supply and Sanitation (JMP) updated in 2015. This document also provides key information on selected health and development issues for TWG WSH member countries. The member countries covered in this report are: Brunei Darussalam Cambodia China Indonesia Japan the Lao People s Democratic Republic Malaysia Mongolia Myanmar the Philippines the Republic of Korea Singapore Thailand and Viet Nam. Previous documents prepared by WHO for the TWG WSH include extensive analyses of the drinking-water sanitation and hygiene sector as a whole based on country-level information. A key finding of this report is that the TWG WSH region has succeeded in meeting the Millennium Development Goal (MDG) target for drinking-water and sanitation which is to halve by 2015 the proportion of the population without sustainable access to safe drinking-water and basic sanitation (UN 2017). Individually nine TWG WSH countries achieved the MDG sanitation target but four countries (i.e. Cambodia Indonesia Mongolia and the Philippines) did not. All TWG WSH countries met the MDG drinking-water target except Mongolia which fell short of the target by 13 percentage points. Overall 77% of people in the TWG WSH region are using improved sanitation facilities whereas 94% are using improved drinking-water sources (UNICEF and WHO 2015). Despite an impressive effort made to provide drinking-water and sanitation infrastructure to the residents in this region about one quarter of the population still lacks access to improved sanitation and 7% lacks access to improved drinking-water. Water-related diseases including diarrhoeal diseases are significant causes of death among children under 5 years old in the region. Almost 30 000 people in the TWG WSH region especially children under 5 die each year due to water sanitation and hygiene related diseases (WHO 2014).
This report sets out the recommendations of an international group of experts relating to developments in the quality assurance of medicines and specifications for drug substances and dosage forms. It contains guidelines of direct relevance to the UN Prequalification Programme for Priority Essential Medicines and for quality control laboratories, including procedures governing the assessment of pharmaceutical products for procurement by UN agencies and for assessing the acceptability of quality control laboratories. It also includes discussion regarding several monographs for inclusion in the International Pharmacopoeia, relating to antiretrovirals, including fixed-dose combinations, TB medicines and antimalarial and paediatric medicines.
Social justice is a matter of life and death. It affects the way people live, their consequent chance of illness, and their risk of premature death. We watch in wonder as life expectancy and good health continue to increase in parts of the world and in alarm as they fail to improve in others.
Overweight and obesity have become urgent global health issues in recent decades. Globally the number of overweight children under the age of 5 years has increased from 32 million in 2000 to 41 million in 2014 corresponding to an increase in prevalence from 5.0% to 6.1%. It is estimated that at the current pace by 2020 some 9% of all children under 5 years will be overweight. Furthermore an increase in adult obesity prevalence has been observed in all countries and globally the prevalence of obesity among adults has doubled from 1980 to 2014 from 5% to 11% for men and from 8% to 15% for women. Overweight and obesity were estimated to account for 3.4 million deaths annually and 93.6 million disability-adjusted life years (DALYs) 1 in 2010. The burden of overweight and obesity is inequitably distributed and affects some population groups and geographical areas more than others based on their social characteristics which are also inequitably distributed. Vulnerability to overweight and obesity might depend on for instance urban or rural residence socioeconomic status ethnicity or the geographical area where people live and their nutritional status in the first 1000 days of life. This report intends to assist policy-makers in the World Health Organization (WHO) Western Pacific Region by contributing to a better understanding of the unequal distribution of overweight and obesity in the Region and by providing policy options to address the social determinants of overweight and obesity. Identifying vulnerable population groups or areas can help policymakers programme managers and other actors to improve programme targeting and increase the effectiveness and improve the health and well-being of the most vulnerable.
This report presents the conclusions of a WHO Expert Committee commissioned to make recommendations on specifications for pesticides used in public health. The aim is to promote the manufacture and use of high quality products that are both acceptable in terms of public health and effective against susceptible vectors of disease. The text includes an outline of the WHO Pesticide Evaluation Scheme (WHOPES) and an overview of recent trends in the various WHO regions.
This report makes recommendations on new therapeutic regimens for visceral and cutaneous leishmaniasis, on the use of rapid diagnostic tests, details on the management of Leishmania-HIV coinfection and consideration of social factors and climate change as risk factors for increased spread. Recommendations for research include the furtherance of epidemiological knowledge of the disease and clinical studies to address the lack of an evidence-based therapeutic regimen for cutaneous and mucocutaneous leishmaniases and post-kala-azar dermal leishmaniasis (PKDL). This report not only provides clear guidance on implementation but should also raise awareness about the global burden of leishmaniasis and its neglect. It puts forward directions for formulation of national control programs and elaborates the strategic approaches in the fight against Leishmaniases. The committee's work reflects the latest scientific and other relevant developments in the field of leishmaniasis that can be considered by member states when setting national programs and making public health decisions.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.